A. Giddabasappa
University of Houston
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. Giddabasappa.
Environmental Health Perspectives | 2007
J. Leigh Leasure; A. Giddabasappa; S. Chaney; J. E. Johnson; Konstantinos Pothakos; Yuen-Sum Lau; Donald A. Fox
Background Low-level developmental lead exposure is linked to cognitive and neurological disorders in children. However, the long-term effects of gestational lead exposure (GLE) have received little attention. Objectives Our goals were to establish a murine model of human equivalent GLE and to determine dose–response effects on body weight, motor functions, and dopamine neurochemistry in year-old offspring. Methods We exposed female C57BL/6 mice to water containing 0, 27 (low), 55 (moderate), or 109 ppm (high) of lead from 2 weeks prior to mating, throughout gestation, and until postnatal day 10 (PN10). Maternal and litter measures, blood lead concentrations ([BPb]), and body weights were obtained throughout the experiment. Locomotor behavior in the absence and presence of amphetamine, running wheel activity, rotarod test, and dopamine utilization were examined in year-old mice. Results Peak [BPb] were < 1, ≤ 10, 24–27, and 33–42 μg/dL in control, low-, moderate- and high-dose GLE groups at PN0–10, respectively. Year-old male but not female GLE mice exhibited late-onset obesity. Similarly, we observed male-specific decreased spontaneous motor activity, increased amphetamine-induced motor activity, and decreased rotarod performance in year-old GLE mice. Levels of dopamine and its major metabolite were altered in year-old male mice, although only forebrain utilization increased. GLE-induced alterations were consistently larger in low-dose GLE mice. Conclusions Our novel results show that GLE produced permanent male-specific deficits. The nonmonotonic dose-dependent responses showed that low-level GLE produced the most adverse effects. These data reinforce the idea that lifetime measures of dose–response toxicant exposure should be a component of the neurotoxic risk assessment process.
Environmental Health Perspectives | 2010
A. Giddabasappa; W. Ryan Hamilton; S. Chaney; W. Xiao; J. E. Johnson; S. Mukherjee; Donald A. Fox
Background Gestational lead exposure (GLE) produces novel and persistent rod-mediated electroretinographic (ERG) supernormality in children and adult animals. Objectives We used our murine GLE model to test the hypothesis that GLE increases the number of neurons in the rod signaling pathway and to determine the cellular mechanisms underlying the phenotype. Results Blood lead concentrations ([BPb]) in controls and after low-, moderate-, and high-dose GLE were ≤ 1, ≤ 10, approximately 25, and approximately 40 μg/dL, respectively, at the end of exposure [postnatal day 10 (PND10)]; by PND30 all [BPb] measures were ≤ 1 μg/dL. Epifluorescent, light, and confocal microscopy studies and Western blots demonstrated that late-born rod photoreceptors and rod and cone bipolar cells (BCs), but not Müller glial cells, increased in a nonmonotonic manner by 16–30% in PND60 GLE offspring. Retinal lamination and the rod:cone BC ratio were not altered. In vivo BrdU (5-bromo-2-deoxyuridine) pulse-labeling and Ki67 labeling of isolated cells from developing mice showed that GLE increased and prolonged retinal progenitor cell proliferation. TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and confocal studies revealed that GLE did not alter developmental apoptosis or produce retinal injury. BrdU birth-dating and confocal studies confirmed the selective rod and BC increases and showed that the patterns of neurogenesis and gliogenesis were unaltered by GLE. Conclusions Our findings suggest two spatiotemporal components mediated by dysregulation of different extrinsic/intrinsic factors: increased and prolonged cell proliferation and increased neuronal (but not glial) cell fate. These findings have relevance for neurotoxicology, pediatrics, public health, risk assessment, and retinal cell biology because they occurred at clinically relevant [BPb] and correspond with the ERG phenotype.
Molecular Vision | 2007
J. E. Johnson; Guy A. Perkins; A. Giddabasappa; S. Chaney; W. Xiao; White Ad; Joshua M. Brown; Jenna Waggoner; Mark H. Ellisman; Donald A. Fox
Molecular Vision | 2016
Elda M. Rueda; J. E. Johnson; A. Giddabasappa; Anand Swaroop; Matthew Brooks; Irena Sigel; Shawnta Y. Chaney; Donald A. Fox
Molecular Vision | 2016
Shawnta Y. Chaney; S. Mukherjee; A. Giddabasappa; Elda M. Rueda; W. Ryan Hamilton; J. E. Johnson; Donald A. Fox
Investigative Ophthalmology & Visual Science | 2012
S. Chaney; S. Mukherjee; A. Giddabasappa; J. E. Johnson; Donald A. Fox
Investigative Ophthalmology & Visual Science | 2009
R. Hamilton; J. E. Johnson; A. Giddabasappa; W. Xiao; M. Wang; Laura J. Frishman; Donald A. Fox
Investigative Ophthalmology & Visual Science | 2009
S. Chaney; A. Giddabasappa; J. E. Johnson; Donald A. Fox
Investigative Ophthalmology & Visual Science | 2009
W. Xiao; X. Wang; A. Giddabasappa; Donald A. Fox
Investigative Ophthalmology & Visual Science | 2009
S. Mukherjee; A. Giddabasappa; W. Xiao; B. Xu; S. Chaney; Donald A. Fox